TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
OKUR

OnKure Therapeutics, Inc.

Healthcare · Biotechnology

2.90$ -0.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OKUR
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.6% 99.8% 85.1% 94.5% 98.3% 97.9%
97.1% 80.9% 72.1% 83.6% 96.4% 95.1%
97.1% 95.9% 72.1% 83.6% 96.4% 95.1%
176.3% 4.4% 440.1% 385.0% 9.6% 9.6%
8.3% 4.0% 34.6% 20.4% 9.2% 9.5%
– – 0.9% 0.6% 0.5% 0.9%
– – 15.8% 9.6% 2.6% 2.3%
-76.3% 95.6% -340.1% -285.0% 90.4% 90.4%
-81.4% -55.0% -356.7% -285.6% -134.7% -344.9%
4.6% 1.2% 83.4% 37.3% 11.6% 21.8%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?